Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced today the appointment of Kemal Malik, MB BS, to its Board of Directors...
Online travel agency Expedia (EXPE) announced the exit of two of its top executives Wednesday in the latest high-profile C-suite reorganization of 2019...
Microsoft's shareholders have defeated two proposals by activist investors calling for the company to add a rank-and-file employee on its board of directors and report on gender disparities in company salaries...
(Bloomberg) -- Larry Page and Sergey Brin just got a $2 billion retirement gift from investors. The Google co-founders, who announced on Tuesday they were stepping down from day-to-day management of parent Alphabet Inc., added about $1 billion each to their net worth as of 10:15 a.m. in New York, after the firm’s shares rose 1.8%. They each own about 6% of the internet giant and still control Alphabet through special voting shares...
(Reuters) - Activist investor Carl Icahn on Wednesday urged HP Inc's shareholders, who agree with the merger with Xerox Holdings Corp, to reach out to the personal computer maker's directors for immediate action...
JACKSONVILLE, Fla., Dec. 3, 2019 /PRNewswire/ -- Black Knight, Inc. (NYSE:BKI), a leading provider of integrated software, data and analytics to the mortgage and real estate industries, announced today that Nancy L. Shanik has been elected to serve on the company's Board of Directors...
Calls for the Company to Review All Strategic Alternatives, Including A Sale Believes that the Shares are Worth a Significant Premium versus the Current Market Price Does Not Believe that any Plan by Management to Continue to Operate Independently Would Exceed the Value Attainable from a Sale Transaction Questions why e.l.f...
Samarth Kulkarni, PhD, CEO of CRISPR Therapeutics (CRSP), has been appointed to Repare’s Board of Directors as an independent director...
In recent months, I have written about a number of market phenomena that present investors with problems. One of these things concerns the use of stock-based options as a means of compensating executives. In one of his letters, Warren Buffett (Trades, Portfolio) criticized the practice, arguing they represent an unfair transfer of wealth from shareholders to managers...
LAFAYETTE, Ind., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Wabash National Corporation(WNC) and its Board of Directors is pleased to announce the appointment of Ms. Terry Bassett to the Company’s Board of Directors and to the Nominating and Corporate Governance and Compensation Committees...
ValueAct Holdings, the investment firm founded by Jeff Ubben (Trades, Portfolio), disclosed its third-quarter portfolio last week, listing two new holdings...
LIVERMORE, Calif., Nov. 20, 2019 (GLOBE NEWSWIRE) -- Performant Financial Corporation (PFMT), (“the Company”), a provider of technology-enabled recovery and related analytics services, today announced that James LaCamp has been appointed to Performant’s Board of Directors...
SAN FRANCISCO, Nov. 19, 2019 /PRNewswire/ -- Boardspan, the market leader in digital governance solutions for high-performing boards, announced the appointment today of Sue Barsamian to its board of directors. Ms. Barsamian is a director of Box, NortonLifeLock, Gainsight, and Xactly Corp and formerly Symantec...
BROOKFIELD, Wis., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Bank holding company CIB Marine Bancshares, Inc. (CIBH) announced today that Mses. Gina Cocking and JoAnn Cotter have been appointed to its Board of Directors, effective November 21, 2019...
Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Mr. Gustavo Giraldo to its Board of Directors, replacing Ms. Sharon Gabrielson. The number of Board members remains at seven...
Immunic, Inc. (IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the appointment of Barclay "Buck" A. Phillips, an established life sciences executive, investor and entrepreneur, to its Board of Directors, effective November 14, 2019...
CPI Card Group Inc. (Nasdaq: PMTS; TSX: PMTS) (“CPI Card Group”), a payment technology company and leading provider of credit, debit and prepaid solutions, today announced the addition of Marc Sheinbaum to its Board of Directors, effective November 14, 2019...
FARGO, N.D., Nov. 14, 2019 (GLOBE NEWSWIRE) -- NI Holdings, Inc. (NODK), an insurance holding company, today announced the appointment of Cindy L. Launer to its Board of Directors, effective immediately...
Eagle Pharmaceuticals, Inc. (EGRX) (“Eagle” or the “Company”) today announced that Douglas L. Braunstein is stepping down from the Company’s Board of Directors, effective November 14, 2019. Mr. Braunstein joined the Board in 2016 and served on its Compensation Committee...
BRIDGEWATER, N.J., Nov. 14, 2019 /PRNewswire/ -- Insmed Incorporated (INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the appointment of Clarissa Desjardins, Ph.D., to its Board of Directors...
today announced the placement of Archana Deskus to the Board of Directors of East West Bancorp. Deskus, Senior Vice President and Chief Information Officer of Hewlett Packard Enterprise (“HPE”), was also appointed to the Board of Directors of East West Bank. The appointment is effective immediately...
SALT LAKE CITY, Nov. 12, 2019 (GLOBE NEWSWIRE) -- The board of directors (the “Board”) of Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, appointed Julie Larson-Green and S. Dawn Smith to its Board, effective January 1, 2020...
TORONTO , Nov. 11, 2019 /CNW/ - NEW WAVE ESPORTS CORP. (the "Company" or "New Wave Esports") (CSE: NWES) is pleased to announce that Richard Carl has been appointed to the Company's board of directors. In connection with his appointment, the Company granted Mr. Carl 200,000 options to purchase common shares of the Company ("Options"). The Options are exercisable at a price of $0.11 and will expire on November 8, 2024 ...
CHAPPAQUA, N.Y., Nov. 11, 2019 /PRNewswire/ -- BioTheryX, Inc. ("BioTheryX"), a clinical stage biotechnology company creating new classes of drugs for unmet medical needs based on targeted protein degradation and multi-kinase inhibition, today announced the appointment of Peter N. Crnkovich to its Board of Directors...